Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 1,615.50
+11.00 (0.69%)
Aug 8, 2025, 3:30 PM JST
Astellas Pharma Employees
Astellas Pharma had 13,643 employees as of March 31, 2025. The number of employees decreased by 1,111 or -7.53% compared to the previous year.
Employees
13,643
Change (1Y)
-1,111
Growth (1Y)
-7.53%
Revenue / Employee
$142,563,439
Profits / Employee
$5,978,597
Market Cap
2,892.25B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 13,643 | -1,111 | -7.53% |
| Mar 31, 2024 | 14,754 | 270 | 1.86% |
| Mar 31, 2023 | 14,484 | -38 | -0.26% |
| Mar 31, 2022 | 14,522 | -933 | -6.04% |
| Mar 31, 2021 | 15,455 | -428 | -2.69% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chugai Pharmaceutical | 5,026 |
| Takeda Pharmaceutical Company | 47,455 |
| HOYA Corporation | 37,909 |
| Daiichi Sankyo Company | 19,765 |
| Otsuka Holdings | 35,338 |
| Shionogi & | 4,955 |
| Olympus | 29,297 |
| M3, Inc. | 15,360 |
Astellas Pharma News
- 1 day ago - Astellas Pharma Inc. 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 24 days ago - Astellas Announces a Partnership with the "Korea Institute of Startup and Entrepreneurship Development", an Umbrella Organization of the "Ministry of SMEs and Startups", a Korean Government Agency, for the Operation of the "Partnership with Global Companies Program" - PRNewsWire
- 25 days ago - China hands 3-1/2-year prison sentence to Astellas' Japanese employee, Nikkei says - Yahoo
- 25 days ago - China jails Japanese businessman for espionage, embassy says - Al Jazeera
- 25 days ago - Chinese court sentences a Japanese man to more than 3 years in prison on espionage charges - Yahoo
- 4 weeks ago - Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study - Benzinga
- 2 months ago - Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan - PRNewsWire
- 2 months ago - Lupin shares in focus after US Court rejects plea in Astellas Patent case - Business Upturn